Skip Navigation

European Heart Journal 1999 20(1):31-37; doi:10.1053/euhj.1998.1202
Copyright © 1999 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow References
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (29)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Burns, S.M.
Right arrow Articles by Schofield, P.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burns, S.M.
Right arrow Articles by Schofield, P.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

The transmyocardial laser revascularization international registry report

S.M. Burnsa,f1, L.D. Sharplesb, S. Taita, N. Cainea, J. Wallworka and P.M. Schofielda

a Departments of Cardiology and Cardiothoracic Surgery and Research and Development Unit, Papworth Hospital NHS Trust, Papworth Everard, Cambridge, U.K.
b MRC Biostatistics Unit, Institute of Public Health, Cambridge, U.K.

accepted June 10, 1998

Abstract

Aims

This report aimed to provide an analysis of the data submitted from Europe and Asia on transmyocardial laser revascularization.

Methods and Results

Prospective data was recorded on 967 patients with intractable angina not amenable to conventional revascularization in 21 European and Asian centres performing transmyocardial laser revascularization using the PLC Medical Systems CO2laser. Patient characteristics, operative details and early complications following transmyocardial laser revascularization were recorded. The in-hospital death rate was 9·7% (95% confidence interval 7·8% to 11·6%). Other early complications were consistent with similar cardiothoracic surgical procedures. There was a decrease of two or more Canadian Cardiovascular Score angina classes in 47·3%, 45·4% and 34·0% of survivors at 3, 6 and 12 months follow-up, respectively (P=0·001 for each). Treadmill exercise time increased by 42s at 3 months (P=0·008), 1min 43s at 6 months (P<0·001) and 1min 50s at 12 months (P<0·001) against pre-operative times of 6min.

Conclusion

Uncontrolled registry data suggest that transmyocardial laser revascularization may lead to a decrease in angina and improved exercise tolerance. It does, however, have a risk of peri-operative morbidity and mortality. Definitive results from randomized controlled trials are awaited.

Key Words: Transmyocardial laser revascularization, Transmyocardial Laser Revascularization Registry

f1 Correspondence: Dr S. M. Burns, Department of Cardiology, Papworth Hospital NHS Trust, Papworth Everard, Cambridge CB3 8RE, U.K.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J Am Coll CardiolHome page
M. B. Leon, R. Kornowski, W. E. Downey, G. Weisz, D. S. Baim, R. O. Bonow, R. C. Hendel, D. J. Cohen, E. Gervino, R. Laham, et al.
A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease
J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1812 - 1819.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
A. Sanni and J. Dunning
Is transmyocardial revascularisation of benefit in addition to coronary artery bypass grafting for patients with diffuse coronary disease?
Interactive CardioVascular and Thoracic Surgery, December 1, 2004; 3(4): 581 - 585.
[Abstract] [Full Text] [PDF]

Home page
 ICVTSHome page
A. Sanni and J. Dunning
Is transmyocardial revascularisation of benefit to people with 'no option' angina?
Interactive CardioVascular and Thoracic Surgery, December 1, 2004; 3(4): 586 - 592.
[Abstract] [Full Text] [PDF]

Home page
 J CARDIOVASC PHARMACOL THERHome page
U. Thadani
Current Medical Management of Chronic Stable Angina
Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S11 - S29.
[Abstract] [PDF]

Home page
 J Am Coll CardiolHome page
M. Saririan and M. J. Eisenberg
Myocardial laser revascularization for the treatment of end-stage coronary artery disease
J. Am. Coll. Cardiol., January 15, 2003; 41(2): 173 - 183.
[Abstract] [Full Text] [PDF]

Home page
 Card Surg AdultHome page
M. Ruel, R. A. Kelly, and F. W. Sellke
Therapeutic Angiogenesis, Transmyocardial Laser Revascularization, and Cell Therapy
Card. Surg. Adult, January 1, 2003; 2(2003): 715 - 750.
[Full Text]

Home page
 Br Med BullHome page
S C Clarke and P M Schofield
Laser revascularisation: Treatments in ischaemic heart disease
Br. Med. Bull., October 1, 2001; 59(1): 249 - 259.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
O. Tjomsland, L. Aaberge, S. M. Almdahl, M. Dragsund, P. Moelstad, K. Saatvedt, and K. Nordstrand
Perioperative cardiac function and predictors for adverse events after transmyocardial laser treatment
Ann. Thorac. Surg., April 1, 2000; 69(4): 1098 - 1103.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
S. C CLARKE and P. M SCHOFIELD
Percutaneous myocardial laser revascularisation
Heart, March 1, 2000; 83(3): 253 - 254.
[Full Text]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.